WATERTOWN, Mass., Oct. 13, 2017 -- Mimecast Limited (NASDAQ:MIME), a leading email and data security company, today announced it will issue a press release reporting financial results for the second quarter of fiscal year 2018 after the close of the market on November 8, 2017.
Mimecast will host a conference call to discuss these financial results for investors and analysts at 4:30 pm EST (UTC-05:00) on November 8, 2017. To access the conference call, dial (844) 815-2878 for the U.S. and Canada and +1 (615) 800-6885 for international callers and enter conference ID# 1077906. The call will also be webcast live on the investor relations section of the Company’s website http://investors.mimecast.com. An audio replay of the call will be available two hours after the live call ends by dialing (855) 859-2056 for U.S. and Canada or +1 (404) 537-3406 for international callers, and entering passcode ID# 1077906. An archive of the webcast will be available on the investor relations section of the company’s website http://investors.mimecast.com.
About Mimecast
Mimecast (NASDAQ:MIME) makes business email and data safer for 27,300 customers and their millions of employees worldwide. Founded in 2003, the company's next-generation cloud-based security, archiving and continuity services protect email and deliver comprehensive email risk management.
More information is available at www.mimecast.com.
Mimecast Social Media Resources
LinkedIn: Mimecast
Facebook: Mimecast
Twitter: @Mimecast
Blog: Challenging Complexity
Press Contact
Alison Raymond Walsh
[email protected]
617-393-7126
Investor Contact
Robert Sanders
[email protected]
617-393-7074


ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
Boeing Secures Multi-Billion Dollar Defense Contracts for F-15IA Jets and E-4B Aircraft Support
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Lockheed Martin Secures $328.5 Million U.S. Defense Contract for Advanced Systems Supporting Taiwan Air Force
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Neuralink Plans Automated Brain Implant Surgeries and Mass Production by 2026
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market
Lloyds Banking Group to Close Invoice Factoring Business by End of 2025
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Vietnam’s EV Taxi Giant GSM Eyes Hong Kong IPO With $2–3 Billion Valuation 



